Lactalis Ingredients Pharma is part of the Lactalis Group, founded in 1933 in France, with a strong track record in dairy transformation and high quality standards. In 2017, the company inaugurated its lactose production plant in Retiers, equipped with state-of-the-art technology, marking the beginning of its development in the pharmaceutical segment, which was further strengthened in 2023 with the launch of Lactalis Ingredients Pharma. Its portfolio includes the Lactalpha range, a pharmaceutical-grade lactose monohydrate with guaranteed nitrite content ≤ 0.1 ppm, available in different grades (50, 100, 150, and 200) to ensure consistency and performance in formulations.